Trevi Therapeutics TRVI
NASDAQ TRVI
$14.91 -0.40 (-2.61%)
At close: Nov 10, 2026 · 4:00 PM EST

Trevi Therapeutics (TRVI) Preferred Shares (2018)

Updated

Trevi Therapeutics (TRVI) reported Preferred Shares of $115.7 million for Q4 2018.

Analysis

Trevi Therapeutics (TRVI) Preferred Shares (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Trevi Therapeutics 2.31 Bn 1.43 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 115.70 Mn
API Access

Trevi Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=TRVI&period=max&api_key=YOUR_API_KEY